Purchases and Sales Made in Q1 2022 in Relmada Therapeutics, Inc. (RLMD)
This table provides information about the institutional ownership of Relmada Therapeutics, Inc. (RLMD) during Q1 2022. The information is specifically focused on institutions that hold shares of RELMADA THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2022
Q1 2022
|
Acuta Capital Partners, LLC
Belmont, CA |
SELL
|
- |
-62K- 15.35% |
$1.04M - $1.67M
|
342K
$130K
|
|
|
May 13, 2022
Q1 2022
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-91.5KClosed |
$1.53M - $2.47M
|
0
$0
|
|
|
May 09, 2022
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-98.5KClosed |
$1.65M - $2.66M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-100K- 50.0% |
$1.67M - $2.7M
|
100K
$38K
|
|
|
May 13, 2022
Q1 2022
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-176K- 20.0% |
$2.95M - $4.76M
|
706K
$268K
|
|
|
May 16, 2022
Q1 2022
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-187K- 39.1% |
$3.13M - $5.05M
|
291K
$111K
|
|
|
May 16, 2022
Q1 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-274K- 49.53% |
$4.59M - $7.41M
|
280K
$106K
|
|
|
May 13, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-307K- 53.59% |
$5.14M - $8.29M
|
266K
$101K
|
|
|
May 16, 2022
Q1 2022
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-400KClosed |
$6.69M - $10.8M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-732KClosed |
$12.2M - $19.7M
|
0
$0
|